Biren Amin Stock Analyst Profile - Piper Sandler Research Coverage - Stocknear

Biren Amin

Stock Analyst at Piper Sandler

(3.7)
# 2486
Out of 5,506 analysts
99
Total ratings
Success rate
Average return

53 Stocks

Name Action PT Current % Upside Ratings Updated
OCUL Ocular Therapeutix
Maintains: Overweight
21 31
11.41 171.69% 2 Oct 3, 2025
MNPR Monopar Therapeutics
Maintains: Overweight
76 95
99.39 -4.42% 2 Sep 25, 2025
SRPT Sarepta Therapeutics
Maintains: Neutral
11 15
22.64 -33.75% 11 Jul 29, 2025
BBIO BridgeBio Pharma
Maintains: Overweight
63 68
52.86 28.64% 3 Jul 14, 2025
ACRS Aclaris Therapeutics
Assumes: Overweight
6
1.86 222.58% 1 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5 4
1.1 263.64% 1 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
20 17
5.9 188.14% 2 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 7
1.33 426.32% 3 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
38 51
48.74 4.64% 1 Apr 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
38
23.23 63.58% 1 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
10 1
n/a n/a 2 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
12
3.7 224.32% 1 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
74 71
29.72 138.9% 2 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
34 4
n/a n/a 3 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
35
14.83 136.01% 1 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
23 21
12.38 69.63% 3 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
91 115
85.07 35.18% 2 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
40 32
23.8 34.45% 2 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 3
4.14 -27.54% 1 Jul 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
120 70
1.61 4247.83% 2 May 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
59 34
n/a n/a 2 Feb 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
51
0.69 7291.3% 1 Jan 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
17
n/a n/a 2 Nov 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
5.74 318.12% 1 Oct 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
4.76 614.29% 1 Oct 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
1050 500
1.54 32367.53% 2 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
9.4 48.94% 1 Jul 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
54
n/a n/a 1 Jul 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
657 691
600 15.17% 2 Jun 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
16 10
3.3 203.03% 1 Jun 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Mar 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 68
n/a n/a 1 Dec 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Hold
11
n/a n/a 4 Sep 16, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10800 2400
n/a n/a 2 Jun 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
61 50
n/a n/a 2 Jun 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 4 Dec 11, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
101
30.94 226.44% 1 Nov 9, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
66 69
137.03 -49.65% 1 Oct 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
155
403.12 -61.55% 5 Jul 11, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Apr 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 3
n/a n/a 1 Mar 7, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
136
2.09 6407.18% 3 Mar 6, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Feb 21, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jan 24, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 46
n/a n/a 1 Feb 3, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
70 60
n/a n/a 1 Jan 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 18
n/a n/a 1 Jan 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
29 28
n/a n/a 1 Jan 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
68 65
n/a n/a 1 Jan 25, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 65
n/a n/a 1 Jan 21, 2016